The Efficacy of Exercise and Alternative Applications of NMES on Pain and Function in Patients With Knee OA

June 18, 2018 updated by: Ekin Aktay, Istanbul University

Istanbul University, Faculty of Health Science, Division of Physiotherapy and Rehabilitation

The aim of the study was to investigate the efficacy of exercise and different size electrodes of neuromuscular electrical stimulation (NMES) applications on pain, range of motion (ROM), muscle strength, function status and depression in knee osteoarthritis.

60 voluntary patients were included in the study and these patients divided into three groups randomly. For Group 1 only exercise, for Group 2 simultaneously active contraction with NMES with standard size electrodes, for Group 3 simultaneously active contraction with NMES with large electrodes applied for 3 days per week, 18 session. Pain was measured with Visual analog Scale (VAS), ROM was measured with digital goniometer, muscle strength was measured with "Hand-held" dynamometer (Lafayette Instrument®, Lafayette, IN), functional status were measured with WOMAC (Western Ontario and McMaster Universities) Index and stair climbing test, balance was analysed with one leg standing test, depression was scored with Hospital Anxiety Depression Scale and patients satisfaction was scored with Global Rating Change Scales. The cases evaluated before and after treatment.

Study Overview

Status

Completed

Conditions

Detailed Description

Aim: This study investigated the effect of neuromuscular electrical stimulation (NMES) was applied with different size electrodes on the functionality, pain, range of motion (ROM), and muscle strength in patients wtih knee osteoarthritis (OA).

Material and Metod: Sixty patients with knee OA who received physical therapy for knee pain and functional disability at Istanbul University, Faculty of Health Sciences, Division of Physiotherapy were included. These patients divided into three groups randomly. Group 1 applied exercise programme. Group 2 performed exercise programme with NMES with standard size electrodes (5×5 cm²). Group 3 performed exercise programme with NMES with large size electrodes (10×20 cm², 3×18 cm², 10 3×7.5 cm², 7×14 cm²) NMES was applied for 20 minutes to Group 2 and Group 3. The patients attended 18 treatment sessions 3 times per week in the physical therapy clinic and underwent assesment before treatment and after 6 weeks of treatment. Pain was measured with Visual Analog Scale (VAS), range of motion (ROM) was measured with digital goniometer, muscle strength was measured with ''Hand-held'' dynomometer, functional status were measured with WOMAC (Western Ontario and McMaster Universities) Index and stair climbing test, balance was analysed with one leg standing test. Patients satisfaction was scored with Global Change Scales.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

47 years to 74 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Acceppting to participate Being between 45-74 years according to the description of the World Health Organisation Being women Having Osteoarthritis on right knee. Having the symptoms of Grade 2-3 according to Kellgren ve Lawrence Classification Having a value below 30 according to Body Mass Index

Exclusion Criteria:

Not accepting to partipate Having left knee Osteoarthritis Having an orthopedic problem on lower extremity Having uncontrollable hypertension Having arteriovenous problem on lower extremity Having confusion about regular participation Having a neurogical problem Having learning and perception problem Having heart implant Being included in physiotherapy and rehabilitation program for knee OA in last 6 month Having injection application for knee in last 6 month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Exercise programme only
The treatment group received only exercise programme. The exercises was done by a physical therapist in clinical center. The treatment group received exercise programme with simultaneously active contraction with NMES with large electrodes.
Active Comparator: Exercise with NMES standard electrodes
The treatment group received exercise programme with simultaneously active contraction with NMES with standard electrodes.The exercises was done by a physical therapist in clinical center. The treatment group received exercise programme with simultaneously active contraction with NMES with large electrodes.
The treatment group received exercise programme with simultaneously active contraction with NMES with large or standart electrodes.
Active Comparator: Exercise with NMES large electrodes
The treatment group received exercise programme with simultaneously active contraction with NMES with large electrodes.The exercises was done by a physical therapist in clinical center. The treatment group received exercise programme with simultaneously active contraction with NMES with large electrodes.
The treatment group received exercise programme with simultaneously active contraction with NMES with large or standart electrodes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analoque Scale
Time Frame: The rest, night time and pain in activity were assessed by VAS before treatment versus after 6 weeks of treatment.
Pain intensity was assessed using the VAS; each patient was asked the pain during the rest, activity, and at night time.
The rest, night time and pain in activity were assessed by VAS before treatment versus after 6 weeks of treatment.
Knee Extensor Muscle Strength
Time Frame: Quadriceps Femoris Muscle strength was measured before treatment versus after 6 weeks of treatment.
Quadriceps Femoris Muscle strength was measured using a Hand-held Dynomometer.
Quadriceps Femoris Muscle strength was measured before treatment versus after 6 weeks of treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Range of Motion
Time Frame: Knee Flexion and extension were measured with Digital Goniometer on sitting position before treatment versus after 6 weeks.
Knee Flexion and extension were measured using a Digital Goniometer.
Knee Flexion and extension were measured with Digital Goniometer on sitting position before treatment versus after 6 weeks.
Knee Range of Motion
Time Frame: Knee Flexion and extension were taken using Digital Goniometer before treatment versus after 6 weeks treatent.
Knee Flexion and extension were taken using a Digital Goniometer on sitting position.
Knee Flexion and extension were taken using Digital Goniometer before treatment versus after 6 weeks treatent.
Muscle Strength using a Hand-held Dynomometer
Time Frame: Hip flexor, extensor, adductor, abductor groups muscles, knee flexor groups muscles strength were measaured before treatment versus after 6 weeks of treatment.
Hip flexor, extensor, adductor, abductor groups muscles, knee flexor groups muscles strength were measaured using a Hand-held Dynomometer.
Hip flexor, extensor, adductor, abductor groups muscles, knee flexor groups muscles strength were measaured before treatment versus after 6 weeks of treatment.
WOMAC (Western Ontario and McMaster Universities Index)
Time Frame: Pain, stiffness and physical function were assessed by WOMAC before treatment versus after 6 weeks of treatment.

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales:[1]

Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright Stiffness (2 items): after first waking and later in the day Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties. The test questions are scored on a scale of 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4).

The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function.

Pain, stiffness and physical function were assessed by WOMAC before treatment versus after 6 weeks of treatment.
Stair Climbimg Test (SCT)
Time Frame: Balance was assessed by SCT before treatment versus after 6 weeks of treatment.
The SCT assesses the ability to ascend and descend a flight of stairs, as well as lower extremity balance.Test included the number of steps, the task requirement (ascent only or ascent/decent combined), or whether the test is timed over a set number of steps or the step count is recorded for a set period of time: 9-step ascend/descend, 4-step ascend/descend (6),3-step ascent cycle duration, 30-second test (12 steps), 3-step measured on 0 - 6 scale of level of assistance., and 6-step fast and self-paced.
Balance was assessed by SCT before treatment versus after 6 weeks of treatment.
One Leg Standing Test
Time Frame: Balance was assessed by One Leg Standing Test before treatment versus after 6 weeks of treatment.
One single-leg standing was assessed balance. Test required the subject to stand with arms by his/her side.Timing was started when the subject raised one foot off the ground. Timing was stopped if the subject displaced the weight-bearing foot, touched the suspended foot to the ground, used the suspended limb to support the weight-bearing limb, or reached the maximum balance time of 30 seconds.
Balance was assessed by One Leg Standing Test before treatment versus after 6 weeks of treatment.
Global Rating Change Scales
Time Frame: Satisfactions was assessed using by Global Rating Change Scales before treatment versus after 6 weeks of treatment.
Rating levels of satisfaction is critical to a successful survey. Global Rating Scale's levels of satisfaction may vary from "Not at all satisfied" to "Very Satisfied" or "Extremely Satisfied," but the scale is not balanced in the same way as Performance or Expectation.
Satisfactions was assessed using by Global Rating Change Scales before treatment versus after 6 weeks of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yıldız Analay Akbaba, Assist Prof., Istanbul University
  • Principal Investigator: Ekin Aktay, MSc, Istanbul University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2016

Primary Completion (Actual)

August 2, 2017

Study Completion (Actual)

August 2, 2017

Study Registration Dates

First Submitted

May 30, 2018

First Submitted That Met QC Criteria

June 18, 2018

First Posted (Actual)

June 27, 2018

Study Record Updates

Last Update Posted (Actual)

June 27, 2018

Last Update Submitted That Met QC Criteria

June 18, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Neuromuscular Electrical Stimulator

Subscribe